Divi's Laboratories Limited (IN:DIVISLAB)
:DIVISLAB
Total Valuation
Divi's Laboratories Limited has a market cap or net worth of ₹1.54T. The enterprise value is ₹1.53T.
Market Cap₹1.54T
Enterprise Value₹1.53T
Share Statistics
Divi's Laboratories Limited has 265,468,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding265,468,570
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Divi's Laboratories Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 12.47%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)12.47%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee9.57M
Profits Per Employee2.25M
Employee Count9,741
Asset Turnover0.55
Inventory Turnover1.16
Valuation Ratios
The current PE Ratio of Divi's Laboratories Limited is 72.7. Divi's Laboratories Limited’s PEG ratio is 1.82.
PE Ratio72.7
PS Ratio15.80
PB Ratio9.84
Price to Fair Value9.84
Price to FCF290.01
Price to Operating Cash Flow94.57
PEG Ratio1.82
Income Statement
In the last 12 months, Divi's Laboratories Limited had revenue of 93.25B and earned 21.91B in profits. Earnings per share was 82.53.
Revenue93.25B
Gross Profit54.55B
Operating Income25.71B
Pretax Income29.16B
Net Income21.91B
EBITDA33.20B
Earnings Per Share (EPS)82.53
Cash Flow
In the last 12 months, operating cash flow was 16.45B and capital expenditures -15.44B, giving a free cash flow of 1.01B billion.
Operating Cash Flow16.45B
Free Cash Flow1.01B
Free Cash Flow per Share3.80
Dividends & Yields
Divi's Laboratories Limited pays an annual dividend of ₹30, resulting in a dividend yield of 0.46%
Dividend Per Share₹30
Dividend Yield0.46%
Payout Ratio32.06%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.87
52-Week Price Change8.30%
50-Day Moving Average6.15K
200-Day Moving Average6.34K
Relative Strength Index (RSI)31.85
Average Volume (3m)6.36K
Important Dates
Divi's Laboratories Limited upcoming earnings date is May 25, 2026, TBA (Confirmed).
Last Earnings DateFeb 11, 2026
Next Earnings DateMay 25, 2026
Ex-Dividend Date―
Financial Position
Divi's Laboratories Limited as a current ratio of 6.94, with Debt / Equity ratio of 0.58%
Current Ratio6.94
Quick Ratio4.65
Debt to Market Cap<0.01
Net Debt to EBITDA-0.13
Interest Coverage Ratio857.00
Taxes
In the past 12 months, Divi's Laboratories Limited has paid 7.25B in taxes.
Income Tax7.25B
Effective Tax Rate0.25
Enterprise Valuation
Divi's Laboratories Limited EV to EBITDA ratio is 44.25, with an EV/FCF ratio of 289.17.
EV to Sales15.75
EV to EBITDA44.25
EV to Free Cash Flow289.17
EV to Operating Cash Flow75.49
Balance Sheet
Divi's Laboratories Limited has ₹32.61B in cash and marketable securities with ₹900.00M in debt, giving a net cash position of ₹31.71B billion.
Cash & Marketable Securities₹32.61B
Total Debt₹900.00M
Net Cash₹31.71B
Net Cash Per Share₹119.45
Tangible Book Value Per Share₹563.72
Margins
Gross margin is 55.57%, with operating margin of 27.57%, and net profit margin of 23.50%.
Gross Margin55.57%
Operating Margin27.57%
Pretax Margin31.27%
Net Profit Margin23.50%
EBITDA Margin35.60%
EBIT Margin31.29%
Analyst Forecast
The average price target for Divi's Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast16.43%
EPS Growth Forecast35.35%